Spirochaetes: The Dual-Nature Phylum of Commensals and Pathogens
- Das K

- 3 days ago
- 12 min read
Spirochaetes constitute a distinct monophyletic phylum of bacteria characterized by their unique spiral or corkscrew morphology and specialized endocellular flagella. This phylum encompasses both commensal members that play beneficial roles in digestive processes and notorious pathogens responsible for some of the most significant human diseases, including syphilis, Lyme disease, and leptospirosis. Within the gastrointestinal tract, spirochaetes occupy diverse niches ranging from the hindgut of termites, where they participate in cellulose digestion, to the colonic epithelium of humans and animals, where they can exist as commensals or opportunistic pathogens.
The genus Brachyspira represents the primary spirochaetal inhabitants of the large intestine in humans and animals. Human intestinal spirochetosis (HIS), caused by Brachyspira aalborgi, Brachyspira pilosicoli, and Brachyspira hominis, presents a complex clinical picture ranging from asymptomatic colonization to chronic watery diarrhea, abdominal pain, and weight loss. Recent 2025 and 2026 case reports have challenged the traditional view that symptomatic infection occurs primarily in immunocompromised individuals, demonstrating that immunocompetent patients with minimal risk factors can develop significant gastrointestinal symptoms requiring antibiotic intervention.
The phylum also includes remarkable commensal species such as Sphaerochaeta coccoides (formerly Spirochaeta coccoides), a spherical, non-motile spirochaete that inhabits termite hindguts and contributes to the digestion of cellulose and hemicellulose breakdown products. This diversity of lifestyle and host interactions makes the Spirochaetes a fascinating subject for understanding bacterial evolution, host adaptation, and the spectrum from mutualism to pathogenicity.
---
Where It Is Found
Spirochaetes occupy a wide range of ecological niches across diverse hosts and environments.
Human Gastrointestinal Tract
The colon and rectum serve as the primary gastrointestinal niche for spirochaetes in humans. Brachyspira species colonize the apical membrane of colonic and rectal epithelial cells, forming a characteristic "false brush border" or "fringe" visible on histological examination. The prevalence of colonization varies dramatically by region and population:
· Developed countries: 2 to 7 percent of individuals
· Developing countries: up to 34 percent of individuals
· Homosexual men and HIV-infected patients: up to 54 percent
This variation reflects differences in hygiene, sanitation, and potential transmission routes including fecal-oral spread.
Animal Reservoirs
Spirochaetes inhabit the gastrointestinal tracts of diverse animal species, serving as reservoirs for zoonotic transmission.
· Swine: Brachyspira hyodysenteriae causes swine dysentery, a severe mucohaemorrhagic colitis in growing pigs
· Poultry: Brachyspira pilosicoli causes avian intestinal spirochetosis (AIS), reducing performance in layer and broiler breeder chickens
· Termites: Sphaerochaeta coccoides inhabits the hindgut of the lower dry-wood termite Neotermes castaneus, where it contributes to cellulose and hemicellulose digestion
· Rodents, guinea pigs, and other mammals harbor diverse spirochaetal species
Environmental Sources
Spirochaetes can be found in water sources, soil, and contaminated environments, serving as transmission vehicles for pathogenic species. Leptospira species persist in water contaminated with animal urine, while Brachyspira may survive in fecal-contaminated environments.
Oral Cavity
The human oral cavity hosts numerous treponemal phylotypes, some of which are associated with gingivitis and periodontitis while others exist as commensals. These oral spirochaetes represent a distinct ecological niche within the broader spirochaetal distribution.
---
1. Taxonomic Insights
Scientific Classification
· Phylum: Spirochaetae (Spirochaetes)
· Class: Spirochaetia
· Orders: Spirochaetales, Leptospirales, Brachyspirales
· Key families: Spirochaetaceae, Brachyspiraceae, Leptospiraceae, Treponemataceae
Major Genera and Species
Brachyspira (Family Brachyspiraceae)
· Brachyspira aalborgi: A human-associated species with limited host range, primarily infecting humans and higher primates
· Brachyspira pilosicoli: A zoonotic species infecting humans, pigs, poultry, and other animals
· Brachyspira hyodysenteriae: The agent of swine dysentery, causing severe mucohaemorrhagic colitis
· Brachyspira hominis: A recently identified human-associated species
Treponema (Family Treponemataceae)
· Treponema pallidum pallidum: The agent of venereal syphilis, transmitted sexually and vertically
· Treponema pallidum endemicum: Causes endemic syphilis (bejel)
· Treponema pallidum pertenue: Causes yaws
· Treponema carateum: Causes pinta
· Numerous oral treponemes associated with periodontal disease
Sphaerochaeta (Family Spirochaetaceae)
· Sphaerochaeta coccoides (formerly Spirochaeta coccoides): A spherical, non-motile species from termite hindguts
· Sphaerochaeta globosa: A spherical species with unique morphology
· Sphaerochaeta pleomorpha: Demonstrates pleomorphic morphology
Leptospira (Family Leptospiraceae)
· Leptospira interrogans: The primary agent of leptospirosis
· Multiple pathogenic and saprophytic species
Borrelia (Family Spirochaetaceae)
· Borrelia burgdorferi: The agent of Lyme disease
· Borrelia recurrentis: Causes relapsing fever
Taxonomic Note
The genus Spirochaeta, one of the oldest named bacterial genera (Ehrenberg 1835), has undergone significant taxonomic revision. The species Spirochaeta coccoides, isolated from termite hindgut, was reclassified based on physiological and genomic characteristics as a member of the novel genus Sphaerochaeta, forming a sister group to the traditional Spirochaeta. This reclassification reflects the growing understanding that spirochaetal morphology extends beyond the classic spiral form to include spherical and pleomorphic shapes.
Genomic Insights
Brachyspira hyodysenteriae
The genome of B. hyodysenteriae strain WA1 is approximately 3 Mb and encodes about 2,122 proteins. Surprisingly, more than half of the predicted proteins show greater similarity to enteric Escherichia coli and Clostridium species than to other sequenced spirochaetes, suggesting extensive horizontal gene transfer from other gut bacteria. This genomic optimization reflects adaptation to the complex, polymicrobial environment of the colon. Key genomic features include:
· Genes for chemotaxis and motility, essential for colonizing colonic crypts and entering goblet cells
· Fifteen predicted proteases potentially involved in epithelial disruption
· Six haemolysin genes contributing to inflammation
· Complete lipooligosaccharide (LOS) biosynthesis genes, with the rfb gene cluster located on a 36 Kb circular plasmid
· A prophage-like gene transfer agent (VSH-1) capable of transferring DNA between strains
Sphaerochaeta coccoides
The genome of Sphaerochaeta coccoides strain SPN1T is 2,227,296 bp with 1,866 protein-coding genes and 58 RNA genes. The genome reflects its specialization for growth in termite hindguts, with enzymatic activities including beta-D-glucosidase, alpha-D-glucosidase, alpha-D-galactosidase, alpha-L-arabinosidase, beta-D-fucosidase, and beta-D-xylosidase. These cell-bound enzymes enable the breakdown of cellulose and hemicellulose degradation products, positioning this spirochaete as a contributor to termite digestion.
Family Characteristics
Spirochaetaceae
The family encompasses spiral-shaped, motile bacteria with endocellular flagella (axial fibrils) that enable characteristic corkscrew motility. Members include both free-living and host-associated species.
Brachyspiraceae
This family consists of anaerobic, spiral-shaped spirochaetes specialized for colonizing the large intestine of vertebrates. They are characterized by their ability to attach to colonic epithelial cells and their role in intestinal disease.
Treponemataceae
Includes pathogenic and commensal species with a wide host range. Pathogenic species are non-cultivable in artificial media, requiring specialized detection methods.
---
2. Clinical Relevance and Pathogenic Actions
Primary Pathogenic Actions
Gastrointestinal Disease
· Induction of chronic watery diarrhea
· Abdominal pain and cramping
· Weight loss and malabsorption
· Colonic epithelial attachment and colonization
· Impairment of water and electrolyte absorption
Systemic Disease (Non-Gastrointestinal Spirochaetes)
· Syphilis: Multistage systemic infection with primary chancre, secondary rash, and tertiary complications including cardiovascular and neurological involvement
· Lyme disease: Tick-borne illness with erythema migrans rash, arthritis, and neurological manifestations
· Leptospirosis: Zoonotic infection with hepatic and renal involvement
Secondary Pathogenic Actions
· Inflammatory responses in colonized tissues
· Potential association with colorectal polyps and cancer
· Possible role in irritable bowel syndrome
· Eosinophilic enterocolitis mimicry
Dual Nature: Commensal vs. Pathogenic
The pathogenicity of intestinal spirochaetes remains debated. In many individuals, Brachyspira colonization occurs without symptoms or inflammation, suggesting a commensal relationship. The presence of an intact epithelial barrier without invasion correlates with asymptomatic carriage. However, in certain host contexts, including immunocompromised states or specific genetic backgrounds, the same organisms can induce symptomatic disease. This dual nature makes clinical decision-making challenging, as treatment may not be indicated for asymptomatic carriers.
---
3. Bioactive Components and Pathogenic Mechanisms
Endocellular Flagella (Axial Fibrils)
The defining structural feature of spirochaetes is the presence of endocellular flagella located in the periplasmic space, wrapped around the cell body. These structures enable the characteristic corkscrew motility that facilitates:
· Penetration of viscous mucus layers
· Colonization of colonic crypts
· End-on attachment to epithelial cells
· Invasion into goblet cells in some species
Lipooligosaccharide (LOS)
Brachyspira species possess lipooligosaccharide rather than full-length lipopolysaccharide. The LOS has been implicated as a potential virulence factor that induces local inflammation in the colon. In B. hyodysenteriae, LOS biosynthesis genes are distributed across the genome rather than clustered in a single locus, with the rfb gene cluster located on a 36 Kb circular plasmid.
Adhesion Mechanisms
Brachyspira species employ specific adhesion mechanisms for epithelial colonization:
· End-on attachment to the apical membrane of colonic and rectal epithelial cells
· Formation of a characteristic "fringe" or "false brush border" visible histologically
· Potential invasion beyond the surface epithelium associated with symptom development
Proteases and Haemolysins
The B. hyodysenteriae genome encodes 15 proteases and 6 haemolysins that likely contribute to pathogenesis:
· Proteases may disrupt colonic enterocytes, exposing the lamina propria
· Haemolysins may contribute to the mucohaemorrhagic characteristic of swine dysentery
· These factors may induce shedding of epithelial cells and inflammation
Gene Transfer Agents (GTAs)
Brachyspira species contain prophage-like gene transfer agents that can transfer random DNA fragments between strains. The VSH-1 GTA in B. hyodysenteriae transfers approximately 7.5 Kb fragments and may facilitate horizontal gene transfer both within and potentially across species barriers. This mechanism likely contributes to the acquisition of enteric bacterial genes that enhance colonic fitness.
Secretory Systems
Only genes for the common secretory pathway have been identified in Brachyspira genomes, and no known toxin-like proteins have been found. This suggests that pathogenesis relies more on attachment, inflammation induction, and host response modulation rather than classic toxin-mediated mechanisms.
---
4. Human Intestinal Spirochetosis: Clinical Presentation and Management
Epidemiology
Human intestinal spirochetosis (HIS) shows marked geographic and population variation in prevalence:
· Global prevalence in developed countries: 2 to 7 percent
· Global prevalence in developing countries: up to 34 percent
· High-risk populations: men who have sex with men (up to 54 percent), HIV-infected individuals, cancer patients
· Geographic distribution: Cases reported worldwide with potential underdiagnosis
Recent 2025 and 2026 case reports have challenged traditional understanding by documenting symptomatic HIS in immunocompetent patients without classical risk factors. This expanding clinical spectrum suggests the condition may be more common and more clinically significant than previously recognized.
Clinical Presentation
The clinical manifestations of HIS range from asymptomatic colonization to significant gastrointestinal symptoms.
Asymptomatic Carriers
· No gastrointestinal symptoms
· Normal endoscopic appearance
· Incidental finding on colonic biopsy
· May represent commensal colonization
Symptomatic Disease
· Chronic watery diarrhea (most common symptom)
· Abdominal pain, typically left lower quadrant
· Unintentional weight loss (reported up to 4 percent of body weight over two months)
· Nausea and vomiting in some cases
· Rarely, rectal bleeding
· Symptoms may persist for months to years
Associated Conditions
· Irritable bowel syndrome
· Eosinophilic enterocolitis
· Colonic polyps, including sessile serrated adenomas/polyps
· Possible association with colorectal cancer
Risk Factors
Traditional risk factors include:
· Immunocompromised states (HIV, cancer, immunotherapy)
· Homosexual men (independent of HIV status)
· Exposure to human or animal feces
· Contaminated water sources
· Close contact with infected individuals or animals
Emerging risk factors identified in recent case reports:
· Contact with poultry (chickens, ducks)
· Pet ownership (dogs, other animals)
· Agricultural or rural environments
Transmission
The primary route of transmission is fecal-oral, with proposed mechanisms including:
· Direct contact with infected individuals
· Contaminated water or food
· Animal contact (zoonotic transmission for B. pilosicoli)
· Sexual transmission, particularly among men who have sex with men
Diagnosis
Histological Diagnosis
The gold standard for HIS diagnosis is histological examination of colonic or rectal biopsies.
· Hematoxylin and eosin staining reveals a basophilic "fringe" or "false brush border" along the epithelial surface
· Warthin-Starry or silver staining accentuates spirochetes
· Immunohistochemistry with anti-Treponema pallidum antibody demonstrates brown staining along the mucosal surface
· Characteristic appearance: thick layer of spirochetes attached to the apical membrane without invasion
Endoscopic Findings
Colonoscopy typically reveals grossly normal colonic mucosa, even in symptomatic patients. This normal appearance can delay diagnosis, as biopsies are not always obtained when the mucosa appears normal.
Molecular Methods
· Polymerase chain reaction (PCR) enables species-level identification
· Fluorescent in situ hybridization (FISH) allows visualization and identification
· Immunomagnetic separation (IMS) offers sensitive detection
· These methods show promise for future diagnostic applications but are not yet standard
Differential Diagnosis
HIS mimics multiple other causes of chronic diarrhea:
· Irritable bowel syndrome
· Inflammatory bowel disease (Crohn's disease, ulcerative colitis)
· Microscopic colitis
· Celiac disease
· Lactose intolerance
· Chronic giardiasis
· Other infectious causes
Treatment
Antibiotic Therapy
Metronidazole is the antibiotic of choice for symptomatic HIS:
· Typical regimen: 500 mg three times daily for 10 days
· High efficacy with complete symptom resolution in most cases
· May require repeat courses if symptoms recur
Treatment Considerations
· Asymptomatic carriers generally do not require treatment
· Decision to treat should consider symptom severity and impact on quality of life
· Recurrence is possible but rare
· Repeat colonoscopy may be indicated if symptoms persist after treatment
Prognosis
Symptomatic patients treated with metronidazole typically achieve complete remission. However, the long-term significance of colonization remains unclear, and associations with colorectal neoplasia warrant ongoing surveillance.
---
5. Beneficial Spirochaetes: Termite Hindgut Symbionts
Sphaerochaeta coccoides (Family Spirachaetaceae)
Sphaerochaeta coccoides represents a remarkable departure from the typical spiral morphology of the phylum. This species is:
· Obligately anaerobic
· Gram-negative
· Non-motile
· Spherical, with cells 0.5 to 2.0 micrometers in diameter
· Capable of forming cell aggregates in early growth phase
Ecological Role
Sphaerochaeta coccoides inhabits the hindgut of the lower dry-wood termite Neotermes castaneus, where it participates in the digestion of cellulose and hemicellulose breakdown products. This mutualistic relationship benefits both partners:
· The spirochaete obtains a stable environment and nutrients
· The termite gains enhanced digestive capacity through microbial fermentation
Metabolic Capabilities
The species exhibits specific enzymatic activities that enable utilization of termite gut substrates:
· Substrate utilization: maltose fermented to ethanol, formate, and acetate
· Non-utilized substrates: glucose, galactose, lactate, pyruvate, amino acids, polysaccharides
· Growth: requires yeast extract as sole carbon and energy source (minimum 0.2 percent)
· Enzymatic activities: beta-D-glucosidase, alpha-D-glucosidase, alpha-D-galactosidase, alpha-L-arabinosidase, beta-D-fucosidase, beta-D-xylosidase
· Growth conditions: optimal temperature 30°C, pH range 5.5 to 9.5 with optimum at 7.4
Evolutionary Significance
The discovery of spherical, non-motile spirochaetes challenges traditional concepts of spirochaetal morphology and motility. The reclassification of these species into the genus Sphaerochaeta reflects the growing recognition that the phylum Spirochaetes encompasses greater morphological diversity than previously appreciated.
---
6. Diagnosis and Detection
Direct Detection Methods
Dark-Field Microscopy
· Enables visualization of live spirochaetes based on their characteristic motility
· Useful for Treponema pallidum in primary syphilis lesions
· Less applicable for intestinal spirochaetes
Histological Staining
· Hematoxylin and eosin: shows basophilic fringe along epithelium
· Warthin-Starry silver stain: accentuates spirochetes against tissue background
· Immunohistochemistry: species-specific antibody staining
Culture Methods
· Brachyspira species can be cultured under anaerobic conditions using specialized media
· Treponema pallidum cannot be cultured in artificial media, requiring rabbit inoculation for isolation
· Fastidious nature of many spirochaetes makes culture challenging and time-consuming
Molecular Methods
· Polymerase chain reaction (PCR) enables rapid, sensitive detection
· Species identification possible through sequencing or species-specific primers
· Real-time PCR assays available for Brachyspira species identification in colonic biopsies
· Fluorescent in situ hybridization (FISH) allows visualization and identification in tissue sections
Serologic Testing (for Non-Intestinal Spirochaetes)
Syphilis Serology
· Nontreponemal tests (RPR, VDRL): detect antibodies against lipoidal antigens; useful for screening and monitoring treatment response
· Treponemal tests (FTA-ABS, EIA, chemiluminescence): detect antibodies against T. pallidum proteins; remain positive after treatment
· Reverse syphilis screening algorithm: treponemal test first, followed by nontreponemal test for confirmation
Lyme Disease Serology
· Two-tier testing: ELISA followed by Western blot confirmation
· Detects antibodies against Borrelia burgdorferi
Leptospirosis Diagnosis
· Microscopic agglutination test (MAT)
· Culture from blood or cerebrospinal fluid
· PCR from clinical specimens
---
7. Therapeutic Modulations and Interventions
Antibiotic Treatment
Metronidazole
· First-line therapy for symptomatic human intestinal spirochetosis
· Mechanism: disrupts bacterial DNA synthesis
· Typical course: 500 mg three times daily for 10 days
· High efficacy with complete symptom resolution
· May be repeated for recurrence
Alternative Antibiotics
· Penicillin G: treatment for syphilis
· Doxycycline: treatment for Lyme disease and some spirochetal infections
· Ceftriaxone: alternative for neurosyphilis and disseminated Lyme disease
· Macrolides: alternative for early Lyme disease
Probiotic Interventions for Spirochetosis
Research in avian intestinal spirochetosis demonstrates that probiotic lactobacilli can antagonize Brachyspira and reduce clinical pathology.
· Lactobacillus reuteri LM1 inhibits Brachyspira pilosicoli growth in a pH-dependent manner
· L. reuteri reduces Brachyspira motility and association with epithelial cells through passive co-aggregation
· Oral administration of L. reuteri reduces severity of clinical symptoms, decreases Brachyspira colonization, and protects against associated pathology in animal models
These findings suggest potential for probiotic strategies to prevent or manage intestinal spirochetosis, particularly in high-risk populations or as adjunctive therapy.
Dietary Considerations
While specific dietary interventions for spirochetosis are not well-established, general principles apply:
· Avoid contaminated water and food sources in endemic areas
· Maintain good hygiene practices
· Consider probiotic supplementation to support gut microbiota resilience
· In animal agriculture, dietary management may influence Brachyspira colonization
Vaccine Development
The availability of Brachyspira genome sequences has enabled reverse vaccinology approaches for vaccine development. Several potentially protective protein subunits have been identified for B. hyodysenteriae, offering hope for prevention of swine dysentery and potentially human spirochetosis.
---
8. Clinical Significance Summary
Human Intestinal Spirochetosis
· Emerging recognition of symptomatic disease in immunocompetent individuals
· Diagnosis requires high index of suspicion and colonic biopsy
· Metronidazole provides effective treatment
· Associations with colorectal neoplasia warrant further investigation
· Zoonotic transmission potential for B. pilosicoli
Syphilis
· Resurgent public health problem worldwide
· Multistage disease with protean manifestations
· Diagnosis relies heavily on serologic testing
· Penicillin remains effective treatment
· Congenital syphilis remains preventable with adequate prenatal care
Lyme Disease
· Most common vector-borne disease in temperate regions
· Early diagnosis and treatment prevent late complications
· Expanding geographic range with climate change
· Post-treatment Lyme disease syndrome remains controversial
Leptospirosis
· Zoonotic infection with global distribution
· Occupational and recreational exposure risks
· Can cause severe hepatic and renal disease
· Doxycycline prophylaxis for high-risk exposures
Termite Hindgut Spirochaetes
· Represent beneficial symbiotic relationships
· Contribute to lignocellulose digestion
· Provide models for understanding bacterial evolution and adaptation
---
9. Further Study
Treponema pallidum (Family Treponemataceae)
The causative agent of syphilis remains non-cultivable, requiring specialized research approaches. Recent advances in genome sequencing and recombinant antigen production have enabled improved diagnostic tests. Understanding T. pallidum pathogenesis, immune evasion, and persistence mechanisms continues to be an active research area.
Borrelia burgdorferi (Family Spirochaetaceae)
As the agent of Lyme disease, B. burgdorferi has been extensively studied for its tick-borne transmission, complex life cycle, and ability to disseminate and persist in the host. Research continues on vaccine development, improved diagnostics, and understanding of post-treatment symptoms.
Leptospira interrogans (Family Leptospiraceae)
This zoonotic pathogen causes leptospirosis, a disease of global importance. Research focuses on environmental survival, transmission dynamics, and host immune responses.
Sphaerochaeta Species (Family Spirachaetaceae)
The spherical spirochaetes from termite guts and other environments represent an emerging research area for understanding spirochaetal evolution, morphology, and metabolic specialization.
---
Disclaimer
Spirochaetes encompass both commensal and pathogenic species. Human intestinal spirochetosis is a recognized clinical condition requiring appropriate diagnosis and management. The information presented is for educational purposes only and is not a substitute for professional medical advice. Diagnosis and treatment of spirochetal infections should be undertaken only by qualified healthcare providers.

Comments